InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Masson Kristina. Director active across 1 company, notably Acrivon Therapeutics, Inc.. Cumulatively, 5 reports have been published. History available since 14 November 2022. The latest transaction was filed on 14 August 2024 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
5 of 5 declarations